BVF Partners

Funding rounds backed by BVF Partners.

Export CSV
Funding disclosed in full
$177M
Median round
$88.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Ambrosia Biosciences

Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders

$100MSeries BBiotechUnited States
7 participantsBlue Owl Healthcare OpportunitiesBoulder VenturesBVF PartnersDeep Track CapitalJanus Henderson InvestorsRedmileSamsara BioCapital
Crossbow Therapeutics

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries BBiotechUnited States
13 participantsArkin Bio CapitalBlood Cancer United's Therapy Acceleration ProgramBVF PartnersEli Lilly and CompanyHamilton Square PartnersLibbs VenturesLifeLink VenturesMirae Asset Venture InvestmentMPM BioImpactPfizer VenturesPolaris PartnersSixty Degree CapitalTaiho Ventures